104 related articles for article (PubMed ID: 38950885)
1. Ticagrelor Potentiates Cardioprotection by Remote Ischaemic Preconditioning: the Ticagrelor in Remote Ischaemic Preconditioning (TRIP) Randomized Clinical Trial.
Tsiafoutis I; Zografos T; Karelas D; Varelas P; Manousopoulos K; Nenekidis I; Koutouzis M; Lagadinos P; Koudounis P; Agelaki M; Katsanou K; Oikonomou E; Siasos G; Katsivas A
Hellenic J Cardiol; 2024 Jun; ():. PubMed ID: 38950885
[No Abstract] [Full Text] [Related]
2. Ischemic stroke rates decrease with increased ticagrelor use after acute myocardial infarction in patients treated with percutaneous coronary intervention.
Ulvenstam A; Henriksson R; Söderström L; Mooe T
Eur J Prev Cardiol; 2018 Jul; 25(11):1219-1230. PubMed ID: 29929389
[TBL] [Abstract][Full Text] [Related]
3. Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.
Sloth AD; Schmidt MR; Munk K; Kharbanda RK; Redington AN; Schmidt M; Pedersen L; Sørensen HT; Bøtker HE;
Eur Heart J; 2014 Jan; 35(3):168-75. PubMed ID: 24031025
[TBL] [Abstract][Full Text] [Related]
4. Remote ischaemic conditioning for myocardial infarction or elective PCI: systematic review and meta-analyses of randomised trials.
Haller PM; Vargas KG; Haller MC; Piackova E; Wojta J; Gyöngyösi M; Gersh BJ; Kiss A; Podesser BK; Huber K
Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(1_suppl):82-92. PubMed ID: 29911392
[TBL] [Abstract][Full Text] [Related]
5. Loading doses of ticagrelor versus clopidogrel in preventing periprocedural myocardial infarction in Asian patients with acute coronary syndrome.
Zhang YR; Xue ZK; Chen KY; Xu LX; Wang WD; Tao HY; Liu T; Che JJ; Wang XW; Rha SW; Wang JR; Wang P
Perfusion; 2021 Mar; 36(2):122-129. PubMed ID: 32522095
[TBL] [Abstract][Full Text] [Related]
6. Ticagrelor enhances the cardioprotective effects of ischemic preconditioning in stable patients undergoing percutaneous coronary intervention: the TAPER-S randomized study.
D'Amario D; Galli M; Restivo A; Canonico F; Vergallo R; Migliaro S; Trani C; Burzotta F; Aurigemma C; Laborante R; Romagnoli E; Francese F; Ceccarelli I; Borovac JA; Angiolillo DJ; Tavazzi B; Leone AM; Crea F; Patti G; Porto I
Eur Heart J Cardiovasc Pharmacother; 2024 May; 10(3):190-200. PubMed ID: 38006237
[TBL] [Abstract][Full Text] [Related]
7. Remote ischaemic preconditioning in isolated aortic valve and coronary artery bypass surgery: a randomized trial†.
Moscarelli M; Fiorentino F; Suleiman MS; Emanueli C; Reeves BC; Punjabi PP; Angelini GD
Eur J Cardiothorac Surg; 2019 May; 55(5):905-912. PubMed ID: 30544237
[TBL] [Abstract][Full Text] [Related]
8. Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): a randomized pilot clinical trial.
D'Amario D; Restivo A; Leone AM; Vergallo R; Migliaro S; Canonico F; Galli M; Trani C; Burzotta F; Aurigemma C; Niccoli G; Buffon A; Montone RA; Flex A; Franceschi F; Tinelli G; Limbruno U; Francese F; Ceccarelli I; Borovac JA; Porto I; Crea F
Trials; 2020 Feb; 21(1):192. PubMed ID: 32066489
[TBL] [Abstract][Full Text] [Related]
9. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial.
Hong DM; Lee EH; Kim HJ; Min JJ; Chin JH; Choi DK; Bahk JH; Sim JY; Choi IC; Jeon Y
Eur Heart J; 2014 Jan; 35(3):176-83. PubMed ID: 24014392
[TBL] [Abstract][Full Text] [Related]
10. Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration.
van den Doel MA; Gho BC; Duval SY; Schoemaker RG; Duncker DJ; Verdouw PD
Cardiovasc Res; 1998 Jan; 37(1):76-81. PubMed ID: 9539860
[TBL] [Abstract][Full Text] [Related]
11. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.
Hausenloy DJ; Mwamure PK; Venugopal V; Harris J; Barnard M; Grundy E; Ashley E; Vichare S; Di Salvo C; Kolvekar S; Hayward M; Keogh B; MacAllister RJ; Yellon DM
Lancet; 2007 Aug; 370(9587):575-9. PubMed ID: 17707752
[TBL] [Abstract][Full Text] [Related]
12. Remote Ischaemic PrEconditioning of Human Myocardium (RIPE): study protocol for a double-blinded randomised controlled trial.
Deja MA; Wiaderkiewicz R; Czekaj P; Czech E; Malinowski M; Machej L; Węglarzy A; Kowalówka A; Piekarska M; Szurlej B; Latusek T
Kardiol Pol; 2018; 76(1):136-143. PubMed ID: 28980297
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.
Ge Z; Kan J; Gao X; Raza A; Zhang JJ; Mohydin BS; Gao F; Shao Y; Wang Y; Zeng H; Li F; Khan HS; Mengal N; Cong H; Wang M; Chen L; Wei Y; Chen F; Stone GW; Chen SL;
Lancet; 2024 May; 403(10439):1866-1878. PubMed ID: 38599220
[TBL] [Abstract][Full Text] [Related]
14. Remote ischemic preconditioning and endothelial function in patients with acute myocardial infarction and primary PCI.
Manchurov V; Ryazankina N; Khmara T; Skrypnik D; Reztsov R; Vasilieva E; Shpektor A
Am J Med; 2014 Jul; 127(7):670-3. PubMed ID: 24565591
[TBL] [Abstract][Full Text] [Related]
15. Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial.
Marian MJ; Abu Daya H; Chatterjee A; Al Solaiman F; Sasse MF; Fonbah WS; Workman RW; Johnson BE; Carlson SE; Brott BC; Prabhu SD; Leesar MA
J Am Heart Assoc; 2019 Dec; 8(23):e012844. PubMed ID: 31766977
[TBL] [Abstract][Full Text] [Related]
16. Remote ischaemic preconditioning as a method for perioperative cardioprotection: concepts, applications and future directions.
Healy DA; Clarke Moloney M; McHugh SM; Grace PA; Walsh SR
Int J Surg; 2014 Oct; 12(10):1093-9. PubMed ID: 25152442
[TBL] [Abstract][Full Text] [Related]
17. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
Davies WR; Brown AJ; Watson W; McCormick LM; West NE; Dutka DP; Hoole SP
Circ Cardiovasc Interv; 2013 Jun; 6(3):246-51. PubMed ID: 23696599
[TBL] [Abstract][Full Text] [Related]
18. Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms.
Basalay M; Barsukevich V; Mastitskaya S; Mrochek A; Pernow J; Sjöquist PO; Ackland GL; Gourine AV; Gourine A
Exp Physiol; 2012 Aug; 97(8):908-17. PubMed ID: 22427438
[TBL] [Abstract][Full Text] [Related]
19. Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial.
Silvain J; Lattuca B; Beygui F; Rangé G; Motovska Z; Dillinger JG; Boueri Z; Brunel P; Lhermusier T; Pouillot C; Larrieu-Ardilouze E; Boccara F; Labeque JN; Guedeney P; El Kasty M; Laredo M; Dumaine R; Ducrocq G; Collet JP; Cayla G; Blanchart K; Kala P; Vicaut E; Montalescot G;
Lancet; 2020 Nov; 396(10264):1737-1744. PubMed ID: 33202219
[TBL] [Abstract][Full Text] [Related]
20. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions.
Zografos T
EuroIntervention; 2014 Nov; 10(7):891-2. PubMed ID: 24974810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
